Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Registered drugNo placebo

Denmark

Participants:0–17 years · 18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Optimizing fludarabine phosphate exposure to improve event‑free survival in children and young adults with B‑cell acute lymphoblastic leukemia receiving CAR‑T therapy

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Fludarabine Phosphate

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years
Substances:Blinatumomab

Contact Research Centre

B-cell type acute leukaemia

Recruiting

InvestigationalNo placebo

A Study to Test the Safety and How AZD4512 Works in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:AZD4512

Contact Research Centre

B-cell type acute leukaemia+2

Recruiting

InvestigationalNo placebo

Study of LUMC-BOB1-B7-TCR.

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:LUMC-BOB1-B7-TCR.1

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia

Registered drugNo placebo

Croatia

Participants:0–17 years
Substances:Pegaspargase

Contact Research Centre

B-cell type acute leukaemia+2

Recruiting

Registered drugNo placebo

Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tisagenlecleucel

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study on CD19-CAR T Cells, Fludarabine, and Cyclophosphamide for Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Cd19-Car_Lenti_Allo

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of AZD0486 and Tocilizumab for Adolescents and Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tocilizumab

Contact Research Centre

B-cell type acute leukaemia

Not yet recruiting

Registered drugNo placebo

Phase II study of inotuzumab ozogamicin to prevent relapse in adult high‑risk acute lymphoblastic leukaemia patients after allogeneic stem cell transplant

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Inotuzumab Ozogamicin

Contact Research Centre

B-cell type acute leukaemia+1

Not yet recruiting

Registered drugNo placebo

Comparing human normal immunoglobulin (iv) and a drug combination to prevent infections in adults with B-cell acute lymphoblastic leukemia or B-cell lymphoma treated with CAR-T cells

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amoxicillin Sodium

Contact Research Centre

B-cell type acute leukaemia+6

Not yet recruiting

InvestigationalNo placebo

A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:MB-HUCART19.1

Contact Research Centre

Find therapies in clinical trials near you

16 trials match your criteria

B-cell type acute leukaemia

Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

B-cell type acute leukaemia

Optimizing fludarabine phosphate exposure to improve event‑free survival in children and young adults with B‑cell acute lymphoblastic leukemia receiving CAR‑T therapy

B-cell type acute leukaemia

Study of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia

B-cell type acute leukaemia

A Study to Test the Safety and How AZD4512 Works in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

B-cell type acute leukaemia+2

Study of LUMC-BOB1-B7-TCR.

B-cell type acute leukaemia

Study on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia

B-cell type acute leukaemia+2

Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

B-cell type acute leukaemia

Study on CD19-CAR T Cells, Fludarabine, and Cyclophosphamide for Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

B-cell type acute leukaemia

Study on the Safety and Effectiveness of AZD0486 and Tocilizumab for Adolescents and Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

B-cell type acute leukaemia

Phase II study of inotuzumab ozogamicin to prevent relapse in adult high‑risk acute lymphoblastic leukaemia patients after allogeneic stem cell transplant

B-cell type acute leukaemia+1

Comparing human normal immunoglobulin (iv) and a drug combination to prevent infections in adults with B-cell acute lymphoblastic leukemia or B-cell lymphoma treated with CAR-T cells

B-cell type acute leukaemia+6

A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.